MALIGNANT ATROPHIC PAPULOSIS

MALIGNANT ATROPHIC PAPULOSIS was reported 40 times

MALIGNANT ATROPHIC PAPULOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Blood Viscosity Reducer [EPC] 4 0.0009
1 Complement Inhibitor [EPC] 22 0.0004
2 Lipid Emulsion [EPC] 1 0.0004
3 Prostacycline Vasodilator [EPC] 20 0.0001
4 Interleukin-6 Receptor Antagonist [EPC] 6 0.0000
5 Factor Xa Inhibitor [EPC] 6 0.0000
6 Alkylating Drug [EPC] 5 0.0000
7 Janus Kinase Inhibitor [EPC] 3 0.0000
8 Platelet Aggregation Inhibitor [EPC] 9 0.0000
9 beta-Adrenergic Blocker [EPC] 3 0.0000
10 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
11 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
12 Nonsteroidal Anti-inflammatory Drug [EPC] 8 0.0000
13 Corticosteroid [EPC] 7 0.0000
14 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
15 Vitamin C [EPC] 1 0.0000
16 Kinase Inhibitor [EPC] 1 0.0000